Ana Vidović

848 total citations
74 papers, 585 citations indexed

About

Ana Vidović is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ana Vidović has authored 74 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 18 papers in Molecular Biology and 18 papers in Genetics. Recurrent topics in Ana Vidović's work include Acute Myeloid Leukemia Research (30 papers), Multiple Myeloma Research and Treatments (13 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). Ana Vidović is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), Multiple Myeloma Research and Treatments (13 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). Ana Vidović collaborates with scholars based in Serbia, United States and Russia. Ana Vidović's co-authors include Dragica Tomin, Nada Suvajdžić, Irena Đjunić, Nataša Čolović, Ivo Elezović, Marijana Virijević, Mirjana Mitrović, Nataša Milić, Gradimir Janković and Milica C̆olović and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and European Journal of Cancer.

In The Last Decade

Ana Vidović

63 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Vidović Serbia 13 406 192 165 89 74 74 585
P. Y. Le Prise France 10 285 0.7× 137 0.7× 112 0.7× 156 1.8× 98 1.3× 19 495
E. Koivunen Finland 14 252 0.6× 102 0.5× 89 0.5× 129 1.4× 58 0.8× 24 451
Muhlis Cem Ar Türkiye 14 340 0.8× 120 0.6× 210 1.3× 128 1.4× 22 0.3× 113 655
Anu Korula India 14 394 1.0× 202 1.1× 102 0.6× 209 2.3× 142 1.9× 112 724
S H Advani India 15 261 0.6× 137 0.7× 141 0.9× 162 1.8× 156 2.1× 50 616
Lysiane Molina France 14 544 1.3× 154 0.8× 120 0.7× 159 1.8× 237 3.2× 29 780
F. Brito‐Babapulle United Kingdom 12 368 0.9× 111 0.6× 148 0.9× 52 0.6× 97 1.3× 23 630
Christina Löfgren Sweden 12 261 0.6× 69 0.4× 109 0.7× 102 1.1× 65 0.9× 17 493
Rakhee Kar India 12 211 0.5× 49 0.3× 170 1.0× 52 0.6× 42 0.6× 105 532
Ingemar Winqvist Sweden 13 386 1.0× 113 0.6× 148 0.9× 80 0.9× 47 0.6× 20 729

Countries citing papers authored by Ana Vidović

Since Specialization
Citations

This map shows the geographic impact of Ana Vidović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Vidović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Vidović more than expected).

Fields of papers citing papers by Ana Vidović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Vidović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Vidović. The network helps show where Ana Vidović may publish in the future.

Co-authorship network of co-authors of Ana Vidović

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Vidović. A scholar is included among the top collaborators of Ana Vidović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Vidović. Ana Vidović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kröger, Nicolaus, Dejana Stanisavljević, Zoran Bukumirić, et al.. (2025). High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation. Frontiers in Immunology. 16. 1577924–1577924.
2.
3.
Virijević, Marijana, Zoran Bukumirić, Nada Suvajdžić, et al.. (2024). Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia. Cancers. 16(24). 4209–4209.
4.
Virijević, Marijana, Andrija Bogdanović, Milena Todorović, et al.. (2024). Clinical characteristics and survival outcomes in acute myeloid leukemia patients: Single center experience. 5(3). 295–308.
5.
Suvajdžić, Nada, Marijana Virijević, Mirjana Mitrović, et al.. (2024). Can pharmacogenetics impact the therapeutic effect of cytarabine and anthracyclines in adult acute myeloid leukaemia patients?: A Serbian experience. Journal of Medical Biochemistry. 43(4). 545–555. 1 indexed citations
6.
Mitrović, Mirjana, Zoran Bukumirić, Marijana Virijević, et al.. (2023). Arterial Thrombosis in Patients with Acute Myeloid Leukemia: Incidence and Risk Factors. Cancers. 15(11). 3060–3060. 5 indexed citations
7.
Suvajdžić, Nada, Sonja Pavlović, Milena Mitrović, et al.. (2023). PB1821: THE INFLUENCE OF BCL2, BAX, BAX/BCL2 RATIO AND MDR1 GENE EXPRESSION ON PROGNOSIS OF ADULT DE NOVO ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE. HemaSphere. 7(S3). e47827a9–e47827a9.
8.
Virijević, Marijana, Zoran Bukumirić, Ana Vidović, et al.. (2022). Application of Rotational Thromboelastometry in Patients with Acute Promyelocytic Leukemia. Clinical and Applied Thrombosis/Hemostasis. 28. 2985301313–2985301313. 7 indexed citations
9.
Karan-Djurašević, Teodora, Marijana Virijević, Ana Vidović, et al.. (2017). Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients. Clinical Lymphoma Myeloma & Leukemia. 17(5). 312–319. 21 indexed citations
10.
Leković, Danijela, Mirjana Gotić, Ana Vidović, et al.. (2014). Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis. Medical Oncology. 31(3). 869–869. 31 indexed citations
11.
Bila, Jelena, et al.. (2013). Extramedullary plasmacytoma of the tongue base: A rare presentation of head and neck plasmacytoma. Vojnosanitetski pregled. 70(10). 972–975. 2 indexed citations
12.
Matić, Ivana Z., Nađa Grozdanić, Ana Damjanović, et al.. (2013). Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignancies. Leukemia & lymphoma. 54(12). 2701–2706. 3 indexed citations
13.
Đjunić, Irena, Nada Suvajdžić, Marijana Virijević, et al.. (2012). Prognostic risk score for the survival of elderly patients with acute myeloid leukaemia comprising comorbidities. Medical Oncology. 30(1). 394–394. 9 indexed citations
14.
Tos̆ić, Nataša, Nataša Čolović, Teodora Karan-Djurašević, et al.. (2012). Prognostic Impact of <b><i>NPM1</i></b> Mutations in Serbian Adult Patients with Acute Myeloid Leukemia. Acta Haematologica. 128(4). 203–212. 9 indexed citations
15.
Karan-Djurašević, Teodora, Vuk Palibrk, Vesna Spasovski, et al.. (2012). Mutational Status and Gene Repertoire of IGHV-IGHD-IGHJ Rearrangements in Serbian Patients With Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 12(4). 252–260. 11 indexed citations
16.
Antić, Darko, Ivo Elezović, Nataša Milić, et al.. (2012). Is there a “gold” standard treatment for patients with isolated myeloid sarcoma?. Biomedicine & Pharmacotherapy. 67(1). 72–77. 70 indexed citations
17.
C̆olović, Milica, et al.. (2012). Primary cutaneous large B-cell non-Hodgkin lymphoma in first-degree relatives. Biomedicine & Pharmacotherapy. 66(6). 425–427. 1 indexed citations
18.
Đjunić, Irena, Marijana Virijević, Nataša Čolović, et al.. (2011). Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia. Medical Oncology. 29(3). 2077–2082. 12 indexed citations
19.
C̆olović, Milica, Nataša Čolović, Gradimir Janković, et al.. (2011). Mixed phenotype acute leukemia of T/myeloid type with a prominent cellular heterogeneity and unique karyotypic aberration 45,XY, dic(11;17). International Journal of Laboratory Hematology. 34(3). 290–294. 4 indexed citations
20.
Čolović, Nataša, Dragica Tomin, Ana Vidović, et al.. (2011). Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia. Biomedicine & Pharmacotherapy. 66(8). 578–582. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Y. Le Prise Breakdown of academic impact, for papers by E. Koivunen Breakdown of academic impact, for papers by Muhlis Cem Ar Breakdown of academic impact, for papers by Anu Korula Breakdown of academic impact, for papers by S H Advani Breakdown of academic impact, for papers by Lysiane Molina Breakdown of academic impact, for papers by F. Brito‐Babapulle Breakdown of academic impact, for papers by Christina Löfgren Breakdown of academic impact, for papers by Rakhee Kar Breakdown of academic impact, for papers by Ingemar Winqvist
Rankless by CCL
2026